Castuner

340B Unscripted

SpendMend Pharmacy

Pharmacists and healthcare industry leaders Rob ‘Hoopi’ Nahoopii PharmD, MS, ACE and Greg Wilson PharmD, BCPS, ACE dive deeply into the complicated and contentious 340B Program as well as other pressing Pharmacy matters. Special guests and industry experts pop in frequently to add insights from all sides of the discussion. If you serve in the pharmacy sector, this podcast is a must-listen!

Website des Podcasts

In deiner App anhören

Folgen

100 Folgen

  1. Ep 103 | 340B and the 2026 Midterm Elections -What to Watch For 40:44
  2. Ep 102 | Updates on the 340B Rebate Model Pilot 45:42
  3. Ep 101 | 340B Rebate Model Pilot & Grantee Conference Recap 1:03:32
  4. Ep 100 | Updates in 340B 28:52
  5. Ep 99 | 340B Developments & Policy Discussion 1:19:44
  6. Ep 98 | CMS 2027 OPPS Proposed Rule & 340B Implications 56:32
  7. Ep 97 | HRSA 340B Rebate Model & SUSTAIN 340B Act 56:39
  8. Ep 96 | 340B Coalition Summer Conference Recap 39:57
  9. Ep 95 | 340B in 2026 – Midyear Review 1:07:19
  10. Ep 94 | Updates on GPO Prohibition – Conversation with Emily Cook 57:05
  11. Ep 93 | 340B Patient Definition 1:09:25
  12. Ep 92 | Latest 340B Updates 23:23
  13. Ep 91 | More 340B Updates 47:19
  14. Ep 90 | 340B Updates 42:22
  15. Ep 89 | 340B Pricing Removal & GPO Prohibition Court Case Ruling 51:40
  16. Ep 88 | Hospital Child Sites – Recent Developments with CMS Provider-Based Rules and 340B Child Site Eligibility Timing 51:19
  17. Ep 87 | HRSA 340B Rebate Request For Information (RFI) 1:09:46
  18. Ep 86 | Updates in 340B 34:14
  19. Ep 85 | HRSA Information Collection Request – 340B Enrollment, Registration & Recertification 58:28
  20. Ep 84 | CMS OPPS Drug Acquisition Cost Survey (ODACS) 1:03:49
  21. Ep 83 | 340B Rebates Are on Hold 27:26
  22. Ep 82 | Recap of 340B Developments from 2025 45:37
  23. Ep 81 | 340B Rebate Q&A with Beacon 1:19:54
  24. Ep 80 | 340B Updates, including CMS CY26 OPPS Final Rule and Rebate Developments 47:45
  25. Ep 79 | 340B Rebate Model Update 52:37
  26. Ep 78 | Government Shutdown, Most Favored Nations Pricing and Direct-to-Consumer Pharmacy Supply Chain Discussion 33:05
  27. Ep 77 | DSH Hospital Threats 50:28
  28. Ep 76 | HRSA DRL Updates & 340B Rebate Comments 1:01:45
  29. Ep 75 | 340B Rebate Guidance Update – HRSA FAQs 50:34
  30. Ep 74 | Annual Hospital Recertification & Proposed Changes to OPAIS 30:34
  31. Ep 73 | Coalition Recap & 340B Rebate Guidance Release 43:21
  32. Ep 72 | Insulin & EpiPen 340B Policy Changes for FQHCs 20:31
  33. Ep 71 | 2025 Midyear 340B Review – Conversation with Ted Slafsky 1:00:52
  34. Ep 70 | 340B Updates – IRA Guidance and Rebate Models 32:13
  35. Ep 69 | Quick 340B Update 24:29
  36. Ep 68 | 340B Hot Topics Discussion 1:11:37
  37. Ep 67 | 340B Location Issues – Webinar Follow Up 1:09:15
  38. Ep 66 | OPAIS Database Compliance Tips 1:17:58
  39. Ep 65 | IRA Impact on 340B 1:01:05
  40. Ep 64 | 340B Winter Coalition Conference Recap 43:40
  41. Ep 63 | Provider-Based Rules & 340B 1:00:56
  42. Ep 62 | Updates from Ongoing 340B Litigation 1:07:57
  43. Ep 61 | What Else is Happening in 340B to Start 2025 34:04
  44. Ep 60 | What’s Happening in 340B to Start 2025 48:47
  45. Ep 59 | Recap of 340B Developments in 2024 1:02:51
  46. Ep 58 | Sanofi 340B Credit Model 51:10
  47. Ep 57 | Post-Election Outcome & 340B Implications 54:35
  48. Ep 56 | 2024 General Election Outlook & 340B 55:47
  49. Ep 55 | All About 340B Modifiers 58:43
  50. Ep 54 | 340B Operations Discussion – “Clean Site” Locations 50:19